Frontlight ResearchEarly access
Childhood cancers trials in United States
630 of 933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleHSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- Where
- Birmingham, Houston, St Louis
- Age
- 36 months to 22 years
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03911388 - Phase 1Taking peopleMetarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Where
- Bethesda, Fairway
- Age
- 12 years to 120 years
- People
- 116
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04222413 - Phase 1/2Taking peopleThe Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Where
- Akron, Albany, Albuquerque, Allentown, Anchorage, Ann Arbor, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boise, Boston, Brooklyn, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, East Lansing, El Paso, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Marshfield, Maywood, Memphis, Mesa, Miami, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Nashville, Neptune City, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reno, Richmond, Roanoke, Rochester, Royal Oak, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Tucson, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winfield, Winston-Salem
- Age
- Up to 22 years
- People
- 960 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT04726241 - Phase 1Taking peopleStudy of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid Tumors
- Where
- Boston, Charlottesville, Grand Rapids, Houston, Jacksonville, Los Angeles, New Haven, New Hyde Park, New York, Philadelphia, Providence, Rochester, Salt Lake City, San Francisco, St Louis
- Age
- 12 years and over
- People
- 464 worldwide
- Run by
- Debiopharm International SA
See details and how to joinNCT04855656 · EU 2023-510063-35-00 - Phase 1/2Taking people000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
- Where
- Bethesda, Jacksonville
- Age
- 15 years to 120 years
- People
- 96
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05588141 - No phaseTaking peopleA Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- Where
- Atlanta, Bethesda, Boston, Los Angeles, Salt Lake City, Seattle, Washington D.C.
- Age
- 1 year to 25 years
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05621291 - Phase 4Taking peopleIdentification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- Where
- Baton Rouge, Charlotte, Memphis, San Diego, Tulsa
- Age
- 1 year to 18 years
- People
- 850
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06289673 - Phase 1/2Taking peoplePacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- Where
- Bethesda
- Age
- 12 years to 120 years
- People
- 160
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06303193 - No phaseTaking peopleLet's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
- Where
- St Louis
- Age
- 8 years and over
- People
- 60
- Run by
- Washington University School of Medicine
See details and how to joinNCT06689800 - Phase 2Taking peopleACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Where
- Ann Arbor, Atlanta, Aurora, Cincinnati, Columbus, Durham, Houston, Miami, Philidelphia, Seattle, St Louis, Washington D.C.
- Age
- 12 months to 39 years
- People
- 60 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06838676 - Phase 2Not yet taking people in United StatesStem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
- Where
- Bethesda
- Age
- 4 years to 70 years
- People
- 102
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07524530 - Phase 2Taking peopleIlluminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Where
- Atlanta, Chicago, Columbus, Los Angeles, Philadelphia, Seattle
- Age
- 1 year to 26 years
- People
- 75
- Run by
- BrainChild Bio, Inc
See details and how to joinNCT07680439 - Phase 1Not yet taking people in United StatesT-Cell Therapy Using CD7 Negative T-Cells Expressing CD7 CAR Expressed In Pediatric Patients With Hematological Malignancies.
- Where
- Memphis
- Age
- Up to 21 years
- People
- 32
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07941531 - Phase 2Taking peopleNivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- Where
- Bethesda
- Age
- 12 years and over
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03258567 - Phase 1/2Taking peopleCyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
- Where
- Bethesda
- Age
- 12 years and over
- People
- 55
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04750928 - Phase 2Taking peoplePEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Where
- Ann Arbor, Aurora, Boston, Chicago, Cincinnati, Columbus, Durham, Houston, Miami, Philadelphia, Seattle, St Louis, Washington D.C.
- Age
- 3 years to 39 years
- People
- 120
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05096481 - Phase 1/2Taking peopleLutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Where
- Aurora, Cincinnati, Columbus, Philadelphia
- Age
- 4 years to 39 years
- People
- 65
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05278208 - No phaseTaking peopleProstate Cancer IMAGing IN Early Detection (IMAGINED Trial)
- Where
- La Jolla
- People
- 225
- Run by
- University of California, San Diego
See details and how to joinNCT05882253 - Phase 2Taking peopleTreatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
- Where
- Fort Worth, Memphis, Palo Alto
- Age
- Up to 22 years
- People
- 135
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06023641 - Phase 2Taking peopleComparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
- Where
- San Francisco
- Age
- 12 years and over
- People
- 62
- Run by
- Thomas Hope
See details and how to joinNCT06961084 - Phase 1Taking peopleRNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
- Where
- Gainesville, Washington D.C.
- Age
- 4 years to 39 years
- People
- 24
- Run by
- University of Florida
See details and how to joinNCT07492316 - Phase 2Taking peopleRadiation Therapy Approaches for People With Prostate Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- People
- 126
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07751159 - Phase 2Taking peopleNaxitamab Enabled Transplant-Free Study in High-Risk Neuroblastoma
- Where
- Hershey
- Age
- 1 year to 30 years
- People
- 101
- Run by
- Giselle Sholler
See details and how to joinNCT07932808 - No phaseNot yet taking people in United StatesSkin Cancer Detection in Primary Care With and Without DermaSensor
- Where
- St Louis
- People
- 200
- Run by
- DermaSensor, Inc.
See details and how to joinNCT07940036 - Phase 1/2Taking peopleA Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Where
- Aurora, Boston, Chicago, Dallas, Fargo, New York, Sioux Falls
- Age
- 6 months to 17 years
- People
- 370 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00